TREND-HD - A Trial of Ethyl-EPA (Miraxion™) in Treating Mild to Moderate Huntington's Disease
Public ClinicalTrials.gov record NCT00146211. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double Blind, Randomized, Parallel Group, Placebo-Controlled Trial of Ethyl-EPA (Miraxion™) in Subjects With Mild to Moderate Huntington's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed to determine the effect of 2 gram/day of ethyl-EPA on motor (movement) signs and symptoms of Huntington disease.
Study identification
- NCT ID
- NCT00146211
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 35 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2005 (Type not available)
- Primary completion
- Aug 2007 (Actual)
- Completion
- Jul 2007 (Actual)
- Last update posted
- Dec 27, 2007
2005 – 2007
United States locations
- U.S. sites
- 35
- U.S. states
- 21
- U.S. cities
- 34
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | — | — |
| Mayo Clinic Arizona | Scottsdale | Arizona | — | — |
| University of California San Diego | La Jolla | California | — | — |
| UCLA Medical Center | Los Angeles | California | — | — |
| University of California Davis | Sacramento | California | — | — |
| University of California San Francisco | San Francisco | California | — | — |
| Colorado Neurological Institute | Englewood | Colorado | — | — |
| Institute of Neurodegenerative Disorders | New Haven | Connecticut | — | — |
| University of Florida | Gainesville | Florida | — | — |
| University of Miami | Miami | Florida | — | — |
| University of South Florida | Tampa | Florida | — | — |
| Emory University | Atlanta | Georgia | — | — |
| Medical College of Georgia | Augusta | Georgia | — | — |
| Rush University Medical Center | Chicago | Illinois | — | — |
| University of Chicago | Chicago | Illinois | — | — |
| Indiana University | Indianapolis | Indiana | — | — |
| University of Iowa | Iowa City | Iowa | — | — |
| University of Kansas | Kansas City | Kansas | — | — |
| Hereditary Neurological Disease Centre | Wichita | Kansas | — | — |
| Johns Hopkins University | Baltimore | Maryland | — | — |
| Boston University | Boston | Massachusetts | — | — |
| Massachusetts General Hospital | Charlestown | Massachusetts | — | — |
| University of Michigan | Ann Arbor | Michigan | — | — |
| Washington University School of Medicine | St Louis | Missouri | — | — |
| Albany Medical College | Albany | New York | — | — |
| North Shore-LIJ Health System | Manhasset | New York | — | — |
| Columbia University Medical Center | New York | New York | — | — |
| University of Rochester | Rochester | New York | — | — |
| Ohio State University Parkinson's Center | Columbus | Ohio | — | — |
| Penn State Milton & Hershey Medical College | Hershey | Pennsylvania | — | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | — | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | — | — |
| University of Tennessee-Memphis | Memphis | Tennessee | — | — |
| Baylor College of Medicine | Houston | Texas | — | — |
| University of Virginia | Charlottesville | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00146211, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 27, 2007 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00146211 live on ClinicalTrials.gov.